Multicenter Evaluation of Vancomycin Dosing: Emphasis on Obesity
- 30 June 2008
- journal article
- research article
- Published by Elsevier in The American Journal of Medicine
- Vol. 121 (6) , 515-518
- https://doi.org/10.1016/j.amjmed.2008.01.046
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Vancomycin MIC creep in non-vancomycin-intermediate Staphylococcus aureus (VISA), vancomycin-susceptible clinical methicillin-resistant S. aureus (MRSA) blood isolates from 2001 05Journal of Antimicrobial Chemotherapy, 2007
- Daptomycin versus Standard Therapy for Bacteremia and Endocarditis Caused byStaphylococcus aureusNew England Journal of Medicine, 2006
- Prevalence of Overweight and Obesity in the United States, 1999-2004JAMA, 2006
- Practice Guidelines for the Management of Bacterial MeningitisClinical Infectious Diseases, 2004
- Clinical Features Associated with Bacteremia Due to Heterogeneous Vancomycin‐IntermediateStaphylococcus aureusClinical Infectious Diseases, 2004
- Pharmacodynamics of Vancomycin and Other Antimicrobials in Patients with Staphylococcus aureus Lower Respiratory Tract InfectionsClinical Pharmacokinetics, 2004
- Once-Weekly Dalbavancin versus Standard-of-Care Antimicrobial Regimens for Treatment of Skin and Soft-Tissue InfectionsClinical Infectious Diseases, 2003
- Continuation of a randomized, double-blind, multicenter study of linezolid versus vancomycin in the treatment of patients with nosocomial pneumoniaClinical Therapeutics, 2003
- Linezolid (PNU-100766) versus Vancomycin in the Treatment of Hospitalized Patients with Nosocomial Pneumonia: A Randomized, Double-Blind, Multicenter StudyClinical Infectious Diseases, 2001
- Vancomycin pharmacokinetics in normal and morbidly obese subjectsAntimicrobial Agents and Chemotherapy, 1982